封面
市場調查報告書
商品編碼
2094978

膠囊內視鏡市場:全球市場預測(2026-2032)

Capsule Endoscopy Market - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年,膠囊內視鏡市場將成長至 8.1276 億美元,複合年成長率為 8.07%。

主要市場統計數據
基準年(2025 年) 4.7188億美元
預計年份(2026年) 5.0868億美元
預測年份(2032年) 8.1276億美元
複合年成長率() 8.07%

膠囊內視鏡:執行摘要

膠囊內視鏡正在革新胃腸道診斷,它能夠以微創的方式觀察小腸,甚至大腸和上消化道。這項技術使用可吞嚥的膠囊式攝影機,使其能夠自然地通過消化器官系統,拍攝數千張影像。這有助於評估不明原因的消化道出血、疑似克隆氏症、缺鐵性貧血、小腸腫瘤、息肉症候群等疾病,以及某些傳統內視鏡檢查不完整、禁忌或不適用的情況。其臨床價值在於患者舒適度高、與門診流程相容,並且能夠觀察傳統內視鏡難以到達的解剖區域。

膠囊內視鏡領域的變革性變化

膠囊內視鏡領域正從獨立的影像設備轉變為連網的、工作流程整合的診斷平台。傳統上,膠囊內視鏡主要用於在上消化道和下消化道內視鏡檢查未能發現異常後觀察小腸。如今,隨著醫療系統對能夠減輕檢查負擔、支持早期發現並改善門診和社區醫療服務可及性的、更便於患者使用的診斷工具的需求不斷成長,膠囊內視鏡的臨床應用也在不斷擴展。

人工智慧對膠囊內視鏡的累積影響

人工智慧 (AI) 正成為膠囊內視鏡領域最重要的驅動力之一,因為它能大幅減少影像閱片所需的時間。一次膠囊內視鏡檢查會產生數萬張影像,需要醫生仔細解讀。目前正在開發和評估基於人工智慧的演算法,用於檢測出血、血管擴張、潰瘍、糜爛、息肉、發炎病變和其他黏膜異常,旨在提高影像解讀效率,降低漏診風險,並支持更一致的膠囊內視鏡報告。

膠囊內視鏡引入的區域分析

在亞太地區,膠囊內視鏡的普及應用主要得益於醫院基礎設施的不斷完善、胃腸病學診療能力的提升以及龐大且多元化的人口中胃腸道疾病的高發率。在日本,先進的內視鏡診斷技術早已被廣泛應用於臨床實踐;而在中國和印度,隨著三級醫療機構和私人診斷網路的建設,以及人們對微創胃腸道評估認知的不斷提高,膠囊內鏡的普及程度也在不斷提升。在澳洲和韓國,以品質為中心的診斷流程、先進的影像技術以及利用數位醫療的綜合診療模式仍然是重點領域。

主要集團分析:北約、七國集團、金磚國家、歐盟、東協、海灣合作理事會

在北約成員國中,膠囊內視鏡的普及應用反映了各成員國獨特的醫療保健特點,而非國防協調的結果。其先進應用主要集中在擁有完善的胃腸病學網路、醫療設備監管體系和門診診斷能力的歐洲和北美高所得醫療保健系統。國家醫保報銷政策、採購重點、臨床指南解讀以及醫療保健系統結構仍然是影響其應用的主要因素。

針對各國膠囊內視鏡使用趨勢進行分析。

在中國,隨著人們對胃腸道疾病的認知不斷提高、醫療現代化以及先進內視鏡技術的廣泛應用,膠囊內視鏡在大型醫院和都市區診斷中心的應用日益普及。美國憑藉其完善的胃腸病學網路、門診診斷基礎設施以及針對不明原因消化道出血、疑似克隆氏症和小腸評估的成熟臨床路徑,在膠囊內視鏡的應用方面處於世界領先地位。日本在內視鏡醫學領域高度發達,對膠囊內視鏡影像技術,特別是小腸疾病的診斷,有著深厚的臨床理解。在印度,膠囊內視鏡的應用正透過私立醫院、三級醫療機構以及胃腸病學專科的不斷完善而得到推廣,但其成本效益、醫保報銷以及在主要城市以外地區的普及程度仍然參差不齊。

為膠囊內視鏡行業領導者提供的實用建議

產業領導者應優先考慮經臨床檢驗的創新技術,這些技術能夠提高診斷準確性、減輕影像解讀負擔,並無縫整合到胃腸病學工作流程中。產品開發應著重於高解析度影像、延長運作、提高定位精度、增強電池效率、確保資料傳輸可靠、提供便於病患使用的影像擷取方案,以及能夠減少醫師解讀時間且不影響臨床監督的軟體工具。

與膠囊內視鏡相關的分析方法

本報告基於系統性的二手研究途徑,利用檢驗的臨床、監管和醫療基礎設施資訊來源。報告重點在於同行評審的醫學文獻、胃腸病學會指南、監管文件、保險報銷參考資料、公共衛生資料庫和醫療政策出版物。研究重點包括膠囊內視鏡的臨床適應症、診斷效能考量、膠囊滯留等安全因素、人工智慧在影像解讀中的應用、區域醫療服務可近性以及技術採納模式。

結論:膠囊內視鏡作為一種現代診斷途徑

膠囊內視鏡正日益成為現代胃腸道診斷的重要組成部分,它為觀察小腸提供了對患者友好且具有臨床價值的選擇,同時也支持大腸和上消化道的特定應用。當傳統內視鏡檢查不完整、結果不確定或不適用時,膠囊內視鏡的作用尤其顯著,尤其是在評估不明原因的消化道出血、缺鐵性貧血以及疑似小腸克隆氏症病例時。

目錄

第1章 引言

第2章 分析方法

  • 分析設計
  • 分析框架
  • 市場規模預測
  • 數據三角測量
  • 分析結果
  • 分析的前提條件
  • 分析的局限性

第3章執行摘要

  • 首席體驗長的觀點
  • 市場規模和成長趨勢
  • 市佔率分析(2025 年)
  • FPNV定位矩陣(2025)
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入(GTM)策略

第5章 市場洞察

  • 消費者分析與最終用戶觀點
  • 消費者體驗基準測試
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 成本效益分析(ROI)和成本效益分析(CBA)

第6章:人工智慧(AI)的累積影響(2026 年)

第7章 膠囊內視鏡市場:依類型分類

  • 結腸膠囊內視鏡檢查
  • 食道膠囊內視鏡
  • 小腸膠囊內視鏡檢查

第8章 膠囊內視鏡市場:依產品類型分類

  • 膠囊內視鏡
  • 資料記錄器和穿戴式設備
  • 感應器帶
  • 配件和耗材
  • 服務
    • 安裝
    • 維護
  • 解決方案
    • 桌面分析
    • 人工智慧影像分析

第9章 膠囊內視鏡市場:依技術分類

  • CMOS影像
  • CCD影像
  • 射頻遙測
  • 人體通訊(HBC)

第10章:膠囊內視鏡市場:依應用領域分類

  • 乳糜瀉
  • 大腸直腸癌篩檢
  • 克隆氏症
  • 胃食道逆流症
  • 不明原因消化道出血(OGIB)
  • 小腸腫瘤
  • 潰瘍檢測

第11章 膠囊內視鏡市場:依最終用戶分類

  • 門診手術中心(ASC)
  • 診斷中心
  • 醫院
  • 研究機構

第12章 膠囊內視鏡市場:依年齡層別分類

  • 成人
  • 老年人
  • 兒童

第13章 膠囊內視鏡市場:依通路分類

  • 離線
  • 線上

第14章 膠囊內視鏡市場:依地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第15章 膠囊內視鏡市場:依組別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第16章 膠囊內視鏡市場:依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第17章 競爭格局

  • 市佔率分析(2025 年)
  • FPNV定位矩陣(2025)
  • 市場集中度分析(2025 年)
    • 濃度比(CR)
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析(2025 年)
  • 產品系列分析(2025 年)
  • 基準分析(2025 年)

第18章:公司簡介

  • Advin Health Care
  • Anx Robotica Corp.
  • Beijing Richen-Force Science & Technology Co.,Ltd
  • Biocam Sp. z oo
  • CapsoVision, Inc.
  • Check-Cap Ltd.
  • Covestro AG
  • Duomed Group
  • FUJIFILM Holdings Corporation
  • Given Imaging Ltd.
  • Intromedic Co., Ltd
  • JIFU Medical
  • JINSHAN Science & Technology(Group)Co., Ltd.
  • Medtronic PLC
  • MU Ltd.
  • Olympus Corporation
  • PENTAX Medical
  • RF Co., Ltd.
  • Shangxian Minimal Invasive Inc.
  • STERIS plc
  • STORM Lab UK
  • SynMed Ltd.
Product Code: MRR-3A2E844FDE44

The Capsule Endoscopy Market is projected to grow by USD 812.76 million at a CAGR of 8.07% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 471.88 million
Estimated Year [2026] USD 508.68 million
Forecast Year [2032] USD 812.76 million
CAGR (%) 8.07%

Capsule Endoscopy Executive Summary

Capsule endoscopy is reshaping gastrointestinal diagnostics by enabling minimally invasive visualization of the small bowel and, increasingly, the colon and upper gastrointestinal tract. The technology uses a swallowable camera capsule to capture thousands of images as it moves naturally through the digestive system, supporting evaluation of obscure gastrointestinal bleeding, suspected Crohn's disease, iron-deficiency anemia, small bowel tumors, polyposis syndromes, and selected cases where conventional endoscopy is incomplete, contraindicated, or unsuitable. Its clinical value is anchored in patient comfort, outpatient workflow compatibility, and the ability to visualize anatomical segments that are difficult to access with traditional endoscopes.

Adoption is being strengthened by the rising burden of gastrointestinal disorders, broader access to ambulatory diagnostics, and growing physician preference for noninvasive diagnostic pathways. At the same time, the capsule endoscopy ecosystem is advancing through higher-resolution imaging, longer battery life, improved data recorders, colon capsule applications, magnetic steering research, and artificial intelligence-assisted image interpretation. For healthcare providers, payers, and technology developers, the strategic focus is shifting from device availability alone toward diagnostic yield, workflow efficiency, reimbursement alignment, data integration, safety management, and evidence-based clinical pathways.

Transformative Shifts in the Capsule Endoscopy Landscape

The capsule endoscopy landscape is undergoing a transition from standalone imaging devices toward connected, workflow-integrated diagnostic platforms. Historically, capsule endoscopy was primarily associated with small bowel visualization after negative upper and lower endoscopy. Today, clinical use is broadening as healthcare systems seek patient-friendly diagnostic tools that reduce procedural burden, support earlier detection, and improve access in outpatient and community-based settings.

Several transformative shifts are influencing adoption. First, image quality and frame-rate optimization are improving lesion detection, particularly for vascular lesions, inflammatory changes, ulcers, erosions, polyps, and mucosal abnormalities. Second, software platforms are increasingly central to clinical value, as reading time remains a practical bottleneck for gastroenterology teams. Third, health systems are evaluating capsule endoscopy within broader care pathways, including inflammatory bowel disease monitoring, anemia workups, and colorectal evaluation when colonoscopy is contraindicated or incomplete. Fourth, growing attention to infection control, patient throughput, and procedural capacity is making noninvasive diagnostics more attractive.

The market environment is also shaped by reimbursement rules, clinical guideline updates, training requirements, and medico-legal expectations around missed lesions and retention risk. Capsule retention remains an important safety consideration, particularly in patients with suspected strictures, known Crohn's disease, prior abdominal surgery, or obstructive symptoms, making patency capsule protocols and appropriate patient selection essential. The most successful stakeholders are those aligning technology innovation with validated clinical utility, clear reporting standards, interoperable data systems, and seamless integration into gastroenterology workflows.

Cumulative Impact of Artificial Intelligence on Capsule Endoscopy

Artificial intelligence is becoming one of the most important enablers in capsule endoscopy by addressing the time-intensive nature of image review. A single capsule procedure can generate tens of thousands of images, requiring careful physician interpretation. AI-enabled algorithms are being developed and evaluated to detect bleeding, angioectasia, ulcers, erosions, polyps, inflammatory lesions, and other mucosal abnormalities, with the goal of improving reader efficiency, reducing oversight risk, and supporting more consistent capsule endoscopy reporting.

The cumulative impact of AI extends beyond image triage. AI can support automated landmark recognition, bowel cleanliness scoring, lesion localization, video summarization, and prioritization of clinically relevant frames. These functions can shorten review time, improve report consistency, and support standardized documentation. In inflammatory bowel disease, AI-assisted scoring may help quantify disease activity more consistently, while in bleeding investigations, rapid detection tools can assist earlier clinical decision-making.

However, the integration of artificial intelligence in capsule endoscopy requires strong validation across diverse patient groups, imaging conditions, capsule types, bowel preparation levels, and clinical settings. Regulatory compliance, algorithm transparency, cybersecurity, interoperability with electronic health records, and physician oversight remain critical. AI is therefore best understood as an augmentation layer rather than a replacement for gastroenterology expertise. Its strategic value lies in combining high-volume image analytics with clinical judgment to improve diagnostic confidence, workflow productivity, and patient-centered care.

Key Regional Insights for Capsule Endoscopy Adoption

In Asia-Pacific, capsule endoscopy adoption is supported by expanding hospital infrastructure, growing gastroenterology capacity, and a high burden of gastrointestinal disease across large and diverse populations. Japan has long-standing clinical acceptance of advanced endoscopic diagnostics, while China and India are strengthening access through tertiary hospitals, private diagnostic networks, and rising awareness of minimally invasive gastrointestinal evaluation. Australia and South Korea continue to emphasize quality-driven diagnostic pathways, advanced imaging technologies, and digital health-enabled care coordination.

Europe demonstrates broad clinical engagement with capsule endoscopy, supported by gastroenterology guidelines, academic research, and established endoscopic expertise. Western European countries show stronger integration into hospital and outpatient pathways, while access across parts of Eastern Europe can be shaped by reimbursement coverage, public procurement cycles, and specialist availability. The region's emphasis on evidence-based care and medical device regulation supports structured evaluation of capsule endoscopy for small bowel disease, bleeding investigations, and selected colorectal applications.

North America remains a mature environment for capsule endoscopy due to established gastroenterology practices, strong outpatient care models, and clinical use in small bowel bleeding and inflammatory bowel disease assessment. The United States benefits from specialized digestive disease centers and structured reimbursement pathways for selected indications, while Canada's publicly funded system supports evidence-based deployment, although access can vary by province, referral pathway, and care setting.

Latin America is advancing gradually, led by Brazil and Mexico, where private healthcare networks, specialist centers, and urban hospital systems are expanding access to capsule-based diagnostics. Adoption is influenced by reimbursement variability, specialist availability, uneven access between urban and rural populations, and the need for cost-effective diagnostic pathways in patients with suspected small bowel disease.

In Africa, capsule endoscopy use remains concentrated in major urban and private healthcare centers, with broader adoption constrained by infrastructure, affordability, specialist training, and competing public health priorities. However, long-term opportunities are linked to expanding diagnostic capacity, medical education, referral networks, and regional centers of excellence. The Middle East is witnessing increased interest as tertiary hospitals, medical tourism hubs, and national health modernization programs invest in advanced diagnostic technologies, with GCC countries particularly active in adopting specialist gastrointestinal services and noninvasive diagnostic pathways.

Key Group Insights Across NATO, G7, BRICS, EU, ASEAN, and GCC

Across NATO countries, capsule endoscopy adoption reflects the healthcare characteristics of member states rather than defense alignment, with advanced deployment concentrated in high-income European and North American systems that maintain established gastroenterology networks, medical device oversight, and outpatient diagnostic capacity. National reimbursement policies, procurement priorities, clinical guideline interpretation, and health system structure remain the main determinants of access.

G7 countries represent some of the most clinically developed environments for capsule endoscopy, supported by specialist availability, regulatory sophistication, academic medical centers, and widespread adoption of advanced diagnostic tools. These countries tend to emphasize validated indications, quality assurance, physician training, AI-enabled workflow improvement, and integration of capsule endoscopy into evidence-based gastrointestinal care pathways.

BRICS countries show diverse but important adoption conditions. China and India provide large patient populations and expanding specialty infrastructure, Brazil contributes a strong private healthcare segment, Russia has established tertiary centers despite procurement and geopolitical complexities, and South Africa serves as a regional hub for advanced care on the African continent. Across BRICS, adoption is shaped by urban-rural disparities, reimbursement maturity, specialist distribution, local manufacturing priorities, and the need to improve access to advanced gastrointestinal diagnostics.

The European Union benefits from harmonized medical device regulatory oversight, strong clinical research networks, and guideline-driven gastroenterology practice. EU healthcare systems increasingly assess capsule endoscopy through health technology evaluation, clinical evidence, reimbursement criteria, data protection requirements, and integration into public and private care pathways. This environment supports careful adoption of capsule endoscopy technologies, including AI-assisted reading tools, where regulatory validation and clinical accountability are essential.

Across ASEAN, capsule endoscopy is gaining relevance as healthcare systems expand specialty diagnostics and private hospital networks introduce advanced gastrointestinal services. Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the Philippines differ significantly in reimbursement maturity, specialist density, and infrastructure readiness, but regional demand is supported by rising gastrointestinal disease awareness, medical tourism, and the growth of ambulatory diagnostic pathways.

Within the GCC, capsule endoscopy aligns with national healthcare transformation strategies that prioritize advanced medical technology, specialty care, digital health infrastructure, and improved patient experience. The availability of tertiary care hospitals, high investment in healthcare modernization, and demand for noninvasive diagnostics support adoption, particularly in the United Arab Emirates, Saudi Arabia, Qatar, and other Gulf health systems.

Key Country Insights Shaping Capsule Endoscopy Use

China is expanding capsule endoscopy adoption in large hospitals and urban diagnostic centers, supported by rising gastrointestinal disease awareness, healthcare modernization, and growing use of advanced endoscopic technologies. The United States is a leading country for capsule endoscopy utilization due to established gastroenterology networks, outpatient diagnostic infrastructure, and clinical pathways for obscure gastrointestinal bleeding, suspected Crohn's disease, and small bowel evaluation. Japan is highly advanced in endoscopic practice and has strong clinical familiarity with capsule-based imaging, particularly in small bowel diagnostics. India is increasing use through corporate hospitals, tertiary centers, and growing gastroenterology specialization, though affordability, reimbursement, and access outside major cities remain uneven.

Germany benefits from strong endoscopy expertise, specialist reimbursement systems, and high clinical familiarity with advanced diagnostic technologies. The United Kingdom uses capsule endoscopy within structured gastroenterology services, including applications in small bowel disease and selected colon evaluation pathways, with adoption guided by clinical evidence and health system prioritization. Australia supports capsule endoscopy through specialist referral systems and evidence-based coverage for defined indications. France maintains evidence-led adoption through hospital networks and gastroenterology guidelines, while South Korea combines advanced hospital infrastructure, digital health readiness, and strong endoscopic expertise, making it an important country for innovation-led capsule endoscopy adoption.

Italy and Spain show steady use across public and private care environments, particularly where capsule endoscopy supports small bowel investigation after inconclusive conventional procedures. Canada applies capsule endoscopy through evidence-based provincial systems, with access shaped by referral patterns, reimbursement rules, and regional service availability. Russia has specialist centers capable of delivering capsule endoscopy, although access is shaped by regional disparities, procurement conditions, and healthcare funding priorities. Brazil is the most prominent Latin American setting for advanced gastrointestinal diagnostics, supported by tertiary hospitals and a sizable private healthcare sector. Mexico is expanding access through private hospitals and specialist clinics, particularly in major urban centers where demand for minimally invasive gastrointestinal evaluation is increasing.

Actionable Recommendations for Capsule Endoscopy Industry Leaders

Industry leaders should prioritize clinically validated innovation that improves diagnostic accuracy, reduces reading burden, and integrates smoothly with gastroenterology workflows. Product development should focus on higher-resolution imaging, longer operating duration, improved localization, enhanced battery efficiency, reliable data transmission, patient-friendly ingestion protocols, and software tools that reduce physician review time without compromising clinical oversight.

Healthcare providers should strengthen patient selection protocols, including careful assessment of capsule retention risk and appropriate use of patency testing in patients with suspected strictures, known Crohn's disease, obstructive symptoms, or relevant surgical history. Standardized reporting templates, structured training, and quality assurance programs can improve diagnostic consistency and reduce variability between readers.

Technology developers should invest in AI validation using diverse real-world datasets across regions, indications, bowel preparation quality levels, capsule platforms, and patient demographics. Demonstrating algorithm performance in clinically meaningful outcomes, rather than only image-level detection, will be essential for provider trust, regulatory acceptance, and responsible clinical deployment.

Commercial and access teams should align adoption strategies with reimbursement evidence, guideline inclusion, clinical education, and total workflow value. Partnerships with hospitals, ambulatory endoscopy centers, training institutions, and digital health platforms can improve adoption when supported by service training and clear evidence of efficiency gains. In emerging regions, affordability models, local training, referral-network development, and infrastructure readiness will be critical to expanding access responsibly.

Research Methodology for Capsule Endoscopy Intelligence

This executive summary is based on a structured secondary research approach using verified clinical, regulatory, and healthcare infrastructure sources. The methodology emphasizes peer-reviewed medical literature, gastroenterology society guidelines, regulatory documentation, reimbursement references, public health databases, and healthcare policy publications. Key areas of review include clinical indications for capsule endoscopy, diagnostic performance considerations, safety factors such as capsule retention, AI applications in image interpretation, regional healthcare access, and technology adoption patterns.

The analysis applies evidence triangulation by comparing findings across clinical studies, guideline statements, regulatory frameworks, and healthcare system characteristics. Regional, group, and country insights are interpreted through factors such as specialist availability, hospital infrastructure, reimbursement maturity, public-private healthcare balance, digital health readiness, regulatory environment, and disease burden relevance. The research deliberately excludes market sizing, market share, and forecasting to maintain focus on validated qualitative and data-backed industry intelligence.

All insights are synthesized to support decision-making for healthcare providers, device developers, investors, policy stakeholders, and digital health leaders seeking to understand capsule endoscopy trends without relying on speculative estimates.

Conclusion: Capsule Endoscopy as a Modern Diagnostic Pathway

Capsule endoscopy is becoming an increasingly important component of modern gastrointestinal diagnostics, offering a patient-friendly and clinically valuable option for visualizing the small bowel and supporting selected applications in colon and upper gastrointestinal evaluation. Its strongest role remains in conditions where conventional endoscopy is incomplete, inconclusive, or less suitable, particularly obscure gastrointestinal bleeding, iron-deficiency anemia evaluation, and suspected small bowel Crohn's disease.

The next phase of industry progress will be shaped by AI-assisted interpretation, workflow integration, evidence-based reimbursement, standardized reporting, and region-specific access strategies. Mature healthcare systems are focusing on efficiency, quality, and clinical governance, while emerging regions are building access through specialist centers, private healthcare expansion, and targeted training. Long-term success will depend on balancing innovation with clinical validation, safety protocols, physician education, data interoperability, and equitable access.

For industry leaders, capsule endoscopy should be viewed not only as a device category but as an integrated diagnostic solution combining imaging hardware, intelligent software, clinical workflow design, and patient-centered care delivery.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Capsule Endoscopy Market, by Type

  • 7.1. Introduction
  • 7.2. Colon Capsule Endoscopy
  • 7.3. Esophageal Capsule Endoscopy
  • 7.4. Small Bowel Capsule Endoscopy

8. Capsule Endoscopy Market, by Product Type

  • 8.1. Introduction
  • 8.2. Capsule Endoscopes
  • 8.3. Data Recorders & Wearables
  • 8.4. Sensor Belts
  • 8.5. Accessories & Consumables
  • 8.6. Services
    • 8.6.1. Installation
    • 8.6.2. Maintenance
  • 8.7. Solutions
    • 8.7.1. Desktop Review
    • 8.7.2. AI-assisted Image Review

9. Capsule Endoscopy Market, by Technology

  • 9.1. Introduction
  • 9.2. CMOS Imaging
  • 9.3. CCD Imaging
  • 9.4. RF Telemetry
  • 9.5. Human Body Communication

10. Capsule Endoscopy Market, by Application

  • 10.1. Introduction
  • 10.2. Celiac Disease
  • 10.3. Colon Cancer Screening
  • 10.4. Crohn's Disease
  • 10.5. Gastroesophageal Reflux Disease
  • 10.6. Obscure Gastrointestinal Bleeding (OGIB)
  • 10.7. Small Intestine Tumors
  • 10.8. Ulcer Detection

11. Capsule Endoscopy Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers (ASCs)
  • 11.3. Diagnostic Centers
  • 11.4. Hospitals
  • 11.5. Research Institutes

12. Capsule Endoscopy Market, by Age Group

  • 12.1. Introduction
  • 12.2. Adult
  • 12.3. Geriatric
  • 12.4. Pediatric

13. Capsule Endoscopy Market, by Distribution Channel

  • 13.1. Introduction
  • 13.2. Offline
  • 13.3. Online

14. Capsule Endoscopy Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. Europe
  • 14.3. North America
  • 14.4. Latin America
  • 14.5. Africa
  • 14.6. Middle East

15. Capsule Endoscopy Market, by Group

  • 15.1. NATO
  • 15.2. G7
  • 15.3. BRICS
  • 15.4. European Union
  • 15.5. ASEAN
  • 15.6. GCC

16. Capsule Endoscopy Market, by Country

  • 16.1. China
  • 16.2. United States
  • 16.3. Japan
  • 16.4. India
  • 16.5. Germany
  • 16.6. United Kingdom
  • 16.7. Australia
  • 16.8. France
  • 16.9. South Korea
  • 16.10. Italy
  • 16.11. Canada
  • 16.12. Russia
  • 16.13. Brazil
  • 16.14. Mexico
  • 16.15. Spain

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2025
  • 17.2. FPNV Positioning Matrix, 2025
  • 17.3. Market Concentration Analysis, 2025
    • 17.3.1. Concentration Ratio (CR)
    • 17.3.2. Herfindahl Hirschman Index (HHI)
  • 17.4. Recent Developments & Impact Analysis, 2025
  • 17.5. Product Portfolio Analysis, 2025
  • 17.6. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. Advin Health Care
  • 18.2. Anx Robotica Corp.
  • 18.3. Beijing Richen-Force Science & Technology Co.,Ltd
  • 18.4. Biocam Sp. z o.o.
  • 18.5. CapsoVision, Inc.
  • 18.6. Check-Cap Ltd.
  • 18.7. Covestro AG
  • 18.8. Duomed Group
  • 18.9. FUJIFILM Holdings Corporation
  • 18.10. Given Imaging Ltd.
  • 18.11. Intromedic Co., Ltd
  • 18.12. JIFU Medical
  • 18.13. JINSHAN Science & Technology (Group) Co., Ltd.
  • 18.14. Medtronic PLC
  • 18.15. MU Ltd.
  • 18.16. Olympus Corporation
  • 18.17. PENTAX Medical
  • 18.18. RF Co., Ltd.
  • 18.19. Shangxian Minimal Invasive Inc.
  • 18.20. STERIS plc
  • 18.21. STORM Lab UK
  • 18.22. SynMed Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CAPSULE ENDOSCOPY MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL CAPSULE ENDOSCOPY MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL CAPSULE ENDOSCOPY MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL CAPSULE ENDOSCOPY MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL CAPSULE ENDOSCOPY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 27. GLOBAL CAPSULE ENDOSCOPY MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL CAPSULE ENDOSCOPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL COLON CAPSULE ENDOSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL COLON CAPSULE ENDOSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL COLON CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ESOPHAGEAL CAPSULE ENDOSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ESOPHAGEAL CAPSULE ENDOSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ESOPHAGEAL CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SMALL BOWEL CAPSULE ENDOSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SMALL BOWEL CAPSULE ENDOSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SMALL BOWEL CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CAPSULE ENDOSCOPES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CAPSULE ENDOSCOPES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CAPSULE ENDOSCOPES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DATA RECORDERS & WEARABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DATA RECORDERS & WEARABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DATA RECORDERS & WEARABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SENSOR BELTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SENSOR BELTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SENSOR BELTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ACCESSORIES & CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ACCESSORIES & CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ACCESSORIES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INSTALLATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INSTALLATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INSTALLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MAINTENANCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MAINTENANCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MAINTENANCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DESKTOP REVIEW MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DESKTOP REVIEW MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DESKTOP REVIEW MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AI-ASSISTED IMAGE REVIEW MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AI-ASSISTED IMAGE REVIEW MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AI-ASSISTED IMAGE REVIEW MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CMOS IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CMOS IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CMOS IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CCD IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CCD IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CCD IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RF TELEMETRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RF TELEMETRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RF TELEMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL HUMAN BODY COMMUNICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL HUMAN BODY COMMUNICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL HUMAN BODY COMMUNICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CELIAC DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CELIAC DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CELIAC DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL COLON CANCER SCREENING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL COLON CANCER SCREENING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL COLON CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CROHN'S DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CROHN'S DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CROHN'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL OBSCURE GASTROINTESTINAL BLEEDING (OGIB) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL OBSCURE GASTROINTESTINAL BLEEDING (OGIB) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL OBSCURE GASTROINTESTINAL BLEEDING (OGIB) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SMALL INTESTINE TUMORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SMALL INTESTINE TUMORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SMALL INTESTINE TUMORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ULCER DETECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ULCER DETECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ULCER DETECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AMBULATORY SURGICAL CENTERS (ASCS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AMBULATORY SURGICAL CENTERS (ASCS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AMBULATORY SURGICAL CENTERS (ASCS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 175. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 176. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 177. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. NATO CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 181. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 182. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 185. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 186. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 190. G7 CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 221. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 222. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 225. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 226. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 230. GCC CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL CAPSULE ENDOSCOPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 252. JAPAN CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. JAPAN CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. JAPAN CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. JAPAN CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 256. JAPAN CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 257. JAPAN CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. JAPAN CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. JAPAN CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. JAPAN CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 261. JAPAN CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. INDIA CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. INDIA CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. INDIA CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 265. INDIA CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 266. INDIA CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 267. INDIA CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 268. INDIA CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. INDIA CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 270. INDIA CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 271. INDIA CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 272. GERMANY CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 273. GERMANY CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 274. GERMANY CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. GERMANY CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 276. GERMANY CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 277. GERMANY CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 278. GERMANY CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. GERMANY CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. GERMANY CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 281. GERMANY CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED KINGDOM CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED KINGDOM CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED KINGDOM CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 285. UNITED KINGDOM CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED KINGDOM CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED KINGDOM CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED KINGDOM CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED KINGDOM CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED KINGDOM CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED KINGDOM CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 292. AUSTRALIA CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 293. AUSTRALIA CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. AUSTRALIA CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. AUSTRALIA CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 296. AUSTRALIA CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 297. AUSTRALIA CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 298. AUSTRALIA CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 299. AUSTRALIA CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. AUSTRALIA CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 301. AUSTRALIA CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 302. FRANCE CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 303. FRANCE CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 304. FRANCE CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. FRANCE CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 306. FRANCE CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 307. FRANCE CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 308. FRANCE CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 309. FRANCE CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 310. FRANCE CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 311. FRANCE CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 312. SOUTH KOREA CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 313. SOUTH KOREA CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 314. SOUTH KOREA CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. SOUTH KOREA CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 316. SOUTH KOREA CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 317. SOUTH KOREA CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 318. SOUTH KOREA CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 319. SOUTH KOREA CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 320. SOUTH KOREA CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 321. SOUTH KOREA CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 322. ITALY CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 323. ITALY CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 324. ITALY CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. ITALY CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 326. ITALY CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 327. ITALY CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 328. ITALY CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 329. ITALY CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 330. ITALY CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 331. ITALY CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 332. CANADA CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 333. CANADA CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 334. CANADA CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 335. CANADA CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 336. CANADA CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 337. CANADA CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 338. CANADA CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 339. CANADA CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 340. CANADA CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 341. CANADA CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 342. RUSSIA CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 343. RUSSIA CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 344. RUSSIA CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 345. RUSSIA CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 346. RUSSIA CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 347. RUSSIA CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 348. RUSSIA CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 349. RUSSIA CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 350. RUSSIA CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 351. RUSSIA CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 352. BRAZIL CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 353. BRAZIL CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 354. BRAZIL CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 355. BRAZIL CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 356. BRAZIL CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 357. BRAZIL CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 358. BRAZIL CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 359. BRAZIL CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 360. BRAZIL CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 361. BRAZIL CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 362. MEXICO CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 363. MEXICO CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 364. MEXICO CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 365. MEXICO CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 366. MEXICO CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 367. MEXICO CAPSULE ENDOSCOPY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 368. MEXICO CAPSULE ENDOSCOPY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 369. MEXICO CAPSULE ENDOSCOPY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 370. MEXICO CAPSULE ENDOSCOPY MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 371. MEXICO CAPSULE ENDOSCOPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 372. SPAIN CAPSULE ENDOSCOPY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 373. SPAIN CAPSULE ENDOSCOPY MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 374. SPAIN CAPSULE ENDOSCOPY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 375. SPAIN CAPSULE ENDOSCOPY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 376. SPAIN CAPSULE ENDOSCOPY MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 377. SPAIN CAPSULE ENDOSCOPY